Enhanced Pharmaceutical Composition for Gynecological Diseases

An improved pharmaceutical composition for preventing or treating gynecological diseases, featuring Sarcodon aspratus extracts as active ingredients, with enhanced efficacy, reduced side effects, and personalized treatment options.

The original patent, relating to a pharmaceutical composition for preventing or treating gynecological diseases, has limitations in terms of efficacy, side effects, and individualized treatment. The present inventive concept addresses these limitations by introducing novel formulations, delivery methods, and diagnostic tools, thereby providing a more effective and safer treatment option.

The inventive concept comprises a pharmaceutical composition containing Sarcodon aspratus extracts as active ingredients, with various enhancements. Firstly, the composition can be formulated to provide a sustained release of the extracts over a prolonged period, reducing side effects and improving efficacy. Secondly, the composition can be administered in a transdermal patch form, providing a localized and controlled release of the extracts. Additionally, the composition can include a bioavailability enhancer, increasing the absorption of the extracts into the bloodstream. Furthermore, the inventive concept includes a diagnostic tool for identifying subjects likely to benefit from the composition, based on genetic markers associated with gynecological diseases. Lastly, the composition can be personalized to an individual's genetic profile and medical history, optimizing efficacy and minimizing side effects.

The inventive concept's novelty lies in the combination of Sarcodon aspratus extracts with novel formulations, delivery methods, and diagnostic tools, which are not obvious from the original patent. The sustained release formulation, transdermal patch administration, bioavailability enhancer, diagnostic tool, and personalized treatment options all contribute to the inventive step, providing a significant improvement over the original patent.

Alternative embodiments of the inventive concept could include different formulations, such as nanoparticles or liposomes, to enhance bioavailability. Additionally, the diagnostic tool could be based on other biomarkers, such as hormone levels or gene expression profiles. Furthermore, the personalized treatment options could be expanded to include other factors, such as lifestyle or environmental factors.

The inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the area of women's health. The improved efficacy and safety profile of the composition, combined with the personalized treatment options, make it an attractive solution for patients and healthcare providers. The market potential is substantial, with a growing demand for effective and targeted treatments for gynecological diseases.